Design and challenges of the Randomized Evaluation of Normal versus Augmented Level Replacement Therapy (RENAL) Trial: High-dose versus standard-dose hemofiltration in acute renal failure

Blood Purification

Volumn 26, Issue 5, 2008, Pages 407-416

  Bellomo, Rinaldo ^a   Cass, Alan ^b   Cole, Louise ^b   Finfer, Simon ^b   Gallagher, Martin ^b   Goldsmith, Donna ^b   Myburgh, John ^b   Norton, Robyn ^b   Scheinkestel, Carlos ^b   Banarjee, Ashoke ^b   Bhonagiri, Deepk ^b   Blythe, David ^b   Botha, John ^b   Cade, John ^b   Dobb, Geoff ^b   Eddington, John ^b   Flabouris, Arthas ^b   French, Craig ^b   Garrett, Peter ^b   Henderson, Seton ^b   Ihle, Benno ^b   Joyce, Chris ^b   Kalkoff, Michael ^b   Lipman, Jeff ^b   McArthur, Colin ^b   McGinness, Shay ^b   Milliss, David ^b   Mitchell, Imogen ^b   Morgan, John ^b   Nair, Priya ^b   Orford, Neil ^b   Raza, Asif ^b   Shehabi, Yahya ^b   Tobin, Antony ^b   Totaro, Richard ^b   Turner, Andrew ^b   Wright, Christopher ^b   more..

^a AUSTIN HEALTH   (Australia)

^b NONE

Author keywords

Acute renal failure; Continuous hemodiafiltration; Dialysis; Intensive care; Kidney; Renal replacement therapy, continuous

Indexed keywords

DIALYSIS FLUID;

ACUTE KIDNEY FAILURE; ANTICOAGULATION; BODY WEIGHT; CLINICAL TRIAL; CONTINUOUS HEMODIAFILTRATION; DIALYSIS CATHETER; DIALYSIS MEMBRANE; HUMAN; INFORMED CONSENT; INTENSIVE CARE UNIT; OUTCOME ASSESSMENT; PATIENT SAFETY; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; REVIEW; SURVIVAL RATE; TREATMENT DURATION;

AUSTRALIA; HEMODIAFILTRATION; HUMANS; KIDNEY FAILURE, ACUTE; NEW ZEALAND; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 53949121395     PISSN: 02535068     EISSN: None     Source Type: Journal    
DOI: 10.1159/000148400     Document Type: Review

References (31)

1. Ronco C, Bellomo R, Homel P, et al: Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trail. Lancet 2000;355:26-30.
2. Blake PG: Adequacy of dialysis revisited. Kidney Int 2003;63:1587-1599.
3. Paganini EP, Tapolyai M, Goormastic M, et al: Establishing a dialysis therapy/patient outcome link in intensive care unit acute dialysis for patients with acute renal failure. Am J Kidney Dis 1996;28(suppl 3):S81-S89.
4. Schiffl H, Lang SM, Fischer R: Daily hemodialysis and the outcome of acute renal failure. N Engl J Med 2002;346:305-310.
5. Phu NH, Hien TT, Hoang NT, et al: Hemofiltration and peritoneal dialysis in infection-associated acute renal failure in Vietnam. N Engl J Med 2002;347:895-902.
6. Grootendorst AF, van Bommel EFH, van der Hoven B, van Leengoed LAM, van Osta ALM: High volume hemofiltration improves hemodynamics of endotoxin-induced shock in the pig. J Crit Care 1992;7:67-75.
7. Bellomo R, Kellum JA, Gandhi CR, Pinsly MR: The effect of intensive plasma water exchange by hemofiltration on hemodynamics and soluble mediators in canine endotoxemia. Am J Respir Crit Care Med 2000;161:1429-1436.
8. Honore PM, Jamez, Wauthier M, et al: Prospective evaluation of short-term, high-volume isovolemic hemofiltration on the hemodynamic course and outcome in patients with intractable circulatory failure resulting from septic shock. Crit Care Med 2000;28:3581-3587.
9. Cole L, Bellomo R, Journois D, Davenport P, Baldwin I, Tipping P: High volume hemofiltration in human septic shock. Intensive Care Med 2001;27:978-986.
10. Panigua R, Amato D, Vonesh E, Correa-Rotter R, Ramos A, Moran J, Mujais S: Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial. J Am Soc Nephrol 2002;13:1307-1320.
11. Eknoyan G, Beck GJ, Cheung AK, et al; for the HEMO Study Group: Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med 2002;347:2010-2019.
12. Uchino S, Bellomo R, Morimatsu H, et al: Continuous renal replacement therapy: a worldwide practice survey. Intensive Care Med 2007;33:1563-1570.
13. Eichacker PQ, Gerstenberger EP, Banks SM, Cui X, Natanson C: Meta-analysis of acute lung injury and acute respiratory distress syndrome trials testing low tidal volumes. Am J Respir Crit Care Med 2002;166:1510-1514.
14. Uchino S, Fealy N, Baldwin I, Morimatsu H, Bellomo R: Continuous is not continuous: the incidence and impact of circuit 'downtime' on uremic control during continuous veno-venous hemofiltration. Intensive Care Med 2003;29:1672-1678.
15. Cole L, Bellomo R, Baldwin I, et al: The impact of lactate buffered high volume hemofiltration on acid-base balance. Intensive Care Med 2003;29:1113-1120.
16. Cohen J, Guyatt G, Bernard GR, Calandra T, Cook D, Elbourne D, et al: New strategies for clinical trials in patients with sepsis and septic shock. Crit Care Med 2001;29:880-886.
17. Bagshaw SM, Laupland KB, Doig CJ, et al: Prognosis for long term survival and renal recovery in critically ill patients with severe acute renal failure: a population based study. Crit Care 2005;9:R700-R709.
18. Patel A, ADAVANCE Collaborative Group, MacMahon S, Chalmers J, Neal B, et al: Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial. Lancet 2007;370:829-840.
19. The SAFE Study Investigators: A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 2004;350:2247-2256.
20. Ricci Z, Ronco C: Dose and efficiency of renal replacement therapy: continuous renal replacement therapy versus intermittent hemodialysis versus slow extended daily dialysis. Crit Care Med 2008;36(suppl):S229-S237.
21. Ronco C, Bagshaw SM, Gibney RT, Bellomo R: Outcome comparisons of intermittent and continuous therapies in acute kidney injury: what do they mean? Int J Artif Organs 2008;31:213-220.
22. Ricci Z, Bellomo R, Ronco C: Dose of dialysis in acute renal failure. Clin J Am Soc Nephrol 2006;1:380-388.
23. Monti G, Herrera M, Kindgen-Milles D, Marinho A, Cruz D, Mariano F, Gigliola G, Moretti E, Alessandri E, Robert R, Ronco C; Dose Response Multicentre International Collaborative Initiative Scientific Committee: The DOse REsponse Multicentre International Collaborative Initiative (DO-REMI); in Ronco C, Bellomo R, Kellum JA (eds): Acute Kidney Injury. Contrib Nephrol. Basel, Karger, 2007, vol 156, pp 434-443.
24. Ricci Z, Picardo S, Ronco C: Results from international questionnaires; in Ronco C, Bellomo R, Kellum JA (eds): Acute Kidney Injury. Contrib Nephrol. Basel, Karger, 2007, vol 156, pp 297-303.
25. Ricci Z, Ronco C: Information technology for CRRT and dose delivery calculator; in Ronco C, Bellomo R, Kellum JA (eds): Acute Kidney Injury. Contrib Nephrol. Basel, Karger, 2007, vol 156, pp 197-202.
26. Ricci Z, Polito A, Giorni C, Di Chiara L, Ronco C, Picardo S: Continuous hemofiltration dose calculation in a newborn patient with congenital heart disease and preoperative renal failure. Int J Artif Organs 2007;30:258-261.
27. Ratanarat R, Permpikul C, Ronco C: Renal replacement therapy in acute renal failure: which index is best for dialysis dose quantification? Int J Artif Organs 2007;30:235-243.
28. Huang Z, Letteri JJ, Clark WR, Zhang W, Gao D, Ronco C: Ultrafiltration rate as a dose surrogate in pre-dilution hemofiltration. Int J Artif Organs 2007;30:124-132.
29. Ronco C: Renal replacement therapy for acute kidney injury: let's follow the evidence. Int J Artif Organs 2007;30:89-94.
30. Clark WR, Letteri JJ, Uchino S, Bellomo R, Ronco C: Recent clinical advances in the management of critically ill patients with acute renal failure. Blood Purif 2006;24:487-498.
31. The VA/NIH acute renal failure trial network. Intensity of renal support in critically ill patients with acute kidney failure. N Engl J Med 2008; Epub ahead of print May 20.